Skip to content

Study on the influence of meridian guided pulmonary function training on stroke patients with hemiplegia based on “lung connecting all vessels” theory

Randomized and controlled clinical trial of meridian guided pulmonary function training in evaluating the efficacy of hemiplegic patients with cerebral infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061588
Enrollment
Unknown
Registered
2022-06-29
Start date
2022-06-15
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Control group:Conventional therapy
Experimental group:Meridian guided pulmonary function training

Sponsors

Beijing Daxing District Hospital of Integrated Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis of stroke was in accordance with the diagnostic criteria for stroke formulated by the fourth national cerebrovascular disease academic conference in 1995. The first diagnosis was primary stroke (cerebral infarction or cerebral hemorrhage), which was confirmed by CT or MRI; 2. Evaluation of limb dyskinesia: the score of the Fugl Meyer Assessment Scale (FMA) is 10 to 95; 3. Patients with cerebral infarction had stable vital signs within 3 months of onset, and had no progression of cerebral infarction for more than 48 hours; 4. 18~80 years old, male or female; 5. Fully informed consent and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe lung and heart diseases, severe anemia, malignant hematopoietic system diseases, severe joint diseases, malignant tumors, and other diseases; 2. Those with cognitive impairment or unable to communicate normally, unable to understand and cooperate with respiratory training; 3. Women with mental diseases, lactation, pregnancy, and childbirth; 4. Poor compliance or poor economic conditions, unable to complete clinical observation as required by the protocol; 5. Participants in other clinical trials in recent 3 months.

Design outcomes

Primary

MeasureTime frame
Cardiopulmonary exercise test;

Secondary

MeasureTime frame
Transcranial color-coded duplex sonography, TCCD;Stroke Specific Quality of Life Scale (SS-QOL) ;Stroke syndrome of TCM (SSTCM);Fatigue Severity Scale (FSS);Bethel score;

Countries

China

Contacts

Public ContactPang Haiying

Beijing Daxing District Hospital of Integrated Chinese and Western Medicine

5845790@qq.com+86 010-61278101

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026